~~<i id='DDCFB6FE6C'><strike id='DDCFB6FE6C'><tt id='DDCFB6FE6C'><pre id='DDCFB6FE6C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

author：entertainment 2025-09-07 06:40:50 - browse：451

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Lung cancer screening guidelines updated for cigarette smokers

focus

hotspot

focus

entertainment

explore

hotspot

Illustration:STAT;ScreencaptureOncethedomainofagingTVstars,hawkinghealthproductsfromvitaminstodiabet

WSS

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Bill would allow buprenorphine prescription for addiction via telehealth

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Wegovy trial has doctors encouraged over new possibilities

Why failed clinical trials don’t always spell doom for a new drug

DeepMind touts AlphaFold's new skills as protein folding AI models face off

hotspot

hotspot

focus

Anesthesiologist group: stop taking Ozempic before surgery

After Sarepta trial failure, Duchenne families brace for more debate

Virginia high school admissions case could be legal follow

Humans aren't the only ones with an imagination. Rats have it too

State Dept. review finds Biden bears some blame for Afghanistan failures

A biotech analyst on neuroscience, placebo effect, not over

Heart attack and stroke risk calculators need revising

Wegovy trial has doctors encouraged over new possibilities

After affirmative action ruling, medical educators look to 'holistic review'

Why failed clinical trials don’t always spell doom for a new drug

hotspot

Explaining an after

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Brain injuries and the importance of a second opinion

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

focus

entertainment

explore

hotspot